EDGAR Filing Documents for 0001062993-15-002656

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001062993-15-002656

Filing Date

2015-05-13

Accepted

2015-05-13 17:04:19

Documents

Period of Report

2015-05-13

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	form6k.htm	6-K	5010
2	EXHIBIT 99.1	exhibit99-1.htm	EX-99.1	305305
3	EXHIBIT 99.2	exhibit99-2.htm	EX-99.2	265298
4	EXHIBIT 99.3	exhibit99-3.htm	EX-99.3	7316
5	EXHIBIT 99.4	exhibit99-4.htm	EX-99.4	7304
6	GRAPHIC	logo.jpg	GRAPHIC	6337
7	GRAPHIC	exhibi1.jpg	GRAPHIC	12799
8	GRAPHIC	exhibi2.jpg	GRAPHIC	68933
9	GRAPHIC	exhibi3.jpg	GRAPHIC	39288
10	GRAPHIC	exhibi4.jpg	GRAPHIC	10650
11	GRAPHIC	exhibi5.jpg	GRAPHIC	32020
12	GRAPHIC	exhibi6.jpg	GRAPHIC	10710
13	GRAPHIC	exhibi7.jpg	GRAPHIC	19704
14	GRAPHIC	exhibi8.jpg	GRAPHIC	26327
15	GRAPHIC	exhibi9.jpg	GRAPHIC	44939
16	GRAPHIC	exhibi10.jpg	GRAPHIC	25068
	Complete submission text file	0001062993-15-002656.txt		1001605

Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9

Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627

Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)